ADMA BIOLOGICS, INC.

Other Information.

Insider Trading Arrangements

Our directors and officers may from time to time enter into plans or other arrangements for the purchase or sale of our common stock that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. During the quarter ended June 30, 2026, none of our directors or officers adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

Chief Financial Officer Employment Agreement Amendment

On August 3, 2026, we entered into an amendment (the “Kohler Amendment”) to that certain Employment Agreement, dated November 25, 2025, by and between us and Paul Terence Kohler, Jr., our Chief Financial Officer and Treasurer (the “Kohler Employment Agreement”).

The Kohler Amendment amends the Kohler Employment Agreement to provide that, beginning August 1, 2026, we will provide Mr. Kohler with a monthly stipend of $10,000, net of taxes, for up to 18 months, subject to extension upon approval by our Board, to be used for temporary housing in the Boca Raton, Florida area. If Mr. Kohler relocates full-time to the Boca Raton, Florida area during such period, we will cease providing such monthly stipend and instead provide Mr. Kohler with a one-time relocation payment of $150,000, net of taxes; provided, however, that in the event Mr. Kohler voluntarily terminates employment with us or is terminated for Cause (as defined in the Kohler Employment Agreement) within 18 months following the date such relocation payment is made to Mr. Kohler, Mr. Kohler will be required to reimburse us for such relocation payment.

The Kohler Amendment also amends the severance provisions of the Kohler Employment Agreement. As amended, in the event Mr. Kohler’s employment is terminated by us without Cause or by Mr. Kohler for Good Reason (as each term is defined in the Kohler Employment Agreement), Mr. Kohler will be entitled to certain severance benefits, including 12 months of base salary payable in equal monthly installments, reimbursement of a portion of COBRA premiums for up to 12 months, any earned but unpaid target bonus for the prior performance year, and accelerated vesting of certain equity awards, subject to the terms and conditions set forth in the Kohler Amendment. In the event such termination occurs immediately preceding or within one year following a Change of Control (as defined in the Kohler Employment Agreement), Mr. Kohler will instead be entitled to 15 months of base salary plus a prorated annual target bonus, payable in a lump sum, in each case subject to the terms and conditions set forth in the Kohler Amendment. Mr. Kohler’s entitlement to the severance benefits described above is subject to his execution and non-revocation of a separation agreement and general release.

The foregoing description of the Kohler Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Kohler Amendment, a copy of which is filed as Exhibit 10.1 to this Quarterly Report on Form 10-Q and is incorporated by reference into this Item 5.

Item 6.